platform and payment, volunteers receive a swabbing kit that they must return by mail. Within a few weeks, they receive their test results online. Standard analysis includes information on microbial species found in a person's gut and how this person's gut microbes compare with those of other individuals. The project emphasizes that test takers should not take their personal results as clinical advice.
Data are de-identified and released through the European Bioinformatics Institute, a member of the International Nucleotide Sequence Database Consortium. 8 Test takers can access their own raw data using a unique identifier code.
The BGP combines features of direct-to-consumer (DTC) genomic testing (i.e., the sale of tests directly to paying consumers without the involvement of clinicians) and citizen science in the sense that "lay" people participate in research tasks. Unlike with DTC genomics, the disclosure of personalized test results to users is not the main sales pitch in the case of the gut projects. The main argument in the BGP's recruitment strategy is that users can contribute to science. This raises the question of whether this model is suitable to support recruitment in other research projects in the biomedical field.
To answer this question, we need to understand why participants decide to take part and their views of the BGP's aims and organization. To our knowledge, a study of these aspects in microbiomics has not been carried out so far (similar studies have been conducted for DTC genomics 9, 10 ). An ex-post survey of motivations is not a perfect way to understand why people decided to take part. It is, however, an effective way to identify Purpose: The establishment of databases for research in human microbiomics is dependent on the recruitment of sufficient numbers and diversity of participants. Factors that support or impede participant recruitment in studies of this type have not yet been studied.
Methods:
We report the results of a survey aimed at establishing the motivations of participants in the British Gut Project, a research project that relies on volunteers to provide samples and to help fund the project.
Results:
The two most frequently reported motivations for participation were altruism and solidarity. Low education levels appeared to be a recruitment obstacle. More than half of our 151 respondents said they would participate in further citizen-science projects; 38% said they would not participate in a similar project if it was for-profit or in a project that did not release data sets in repositories accessible to scientists (30%).
Conclusions:
The desire to take part in research was reported as a key motivation for participation in the British Gut Project (BGP). Such prosocial motivations can be mobilized for the establishment of large data sets for research.
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MATERIALS AND METHODS
In December 2015, after obtaining research ethics approval, we contacted 370 participants in the BGP who had agreed to be recontacted through a dedicated BGP mailing list. Between December 2015 and January 2016, 151 participants completed an online questionnaire that was circulated via e-mail and hosted by the survey service SurveyMonkey. The survey consisted of 10 closed questions. The participation rate was 41%; the demographic characteristics of the responders are reported in Supplementary Figure S1 online. We also obtained the aggregate demographic data of all BGP participants, which enabled us to compare the characteristics of the entire set of BGP participants with those who participated in our survey.
RESULTS
The two most common motivations for participation in the BGP were prosocial: to participate in clinically useful research (78%, n=116) and to help clinicians in the search of cures for medical conditions (79%, n=118). The desire to improve self knowledge and lifestyle figured prominently but to a lesser extent: 39% (n=56) declared they wanted to find a cure for their condition, and 58% (n=87) and 59% (n=88), respectively, said they wanted to learn how to change their diet or find out whether they are healthy. Less than 20% (n=29) declared that they changed their diet after obtaining results or consulted a medical doctor. Supplementary Figure S2 online summarizes these findings.
74 (53%) respondents said that they plan to participate in another citizen-science project, and 40% (n=57) said they have not yet decided whether to do so; 37 (n=43) and 34% (n=53), respectively, said they would not participate in a for-profit project or a project that does not release data sets in public repositories. 116 respondents (82%) said that the academic nature of the BGP played a role in their decision to participate. 99 said they believed that there are no risks in projects such as the BGP (71%). Only 1% (n = 2) said the risk is very high.
Some respondents had not received results at the time of our survey. They declared this in the comments section and did not answer questions pertaining to the use of results. Approximately 1 in 10 said they consulted a physician as a result of undergoing the test (11%, n=15), and 2 in 10 (21%, n=29) declared they changed their dietary habits. One-quarter of all respondents (25%, n=35) said they understood their condition better after taking the test. Almost 6 in 10 (57%, n=81) said they believed that their knowledge of microbiomics was sufficient to interpret results correctly.
DISCUSSION
The findings from our research need to be extrapolated with caution to the broader set of participants in the BGP. Most of the respondents to our survey were 65 years old or older, but participants in the BGP are more evenly distributed across age groups. Moreover, although the participation rate was high in relation to comparable studies, 10 our sample size was small and no significant associations could be found between demographic variables and answers to specific questions. It is also important to remember that participants in the survey represent a subset of only the participants in the BGP who chose to be recontacted. The motivations and values of these participants might differ from those of the other participants in the BGP because willingness to be recontacted could be a proxy measure of a positive attitude toward being part of a citizenscience project.
Participants in our study reported that prosocial motivations played an important role in their willingness to participate in the BGP. Such motives are usually described as altruistic or solidaristic. Altruism is typically defined as a helping behavior based on a broad interest to further common, prosocial goals or as prioritizing the needs of others over one's own. Solidarity can be defined as a shared commitment to accept "costs" (e.g., financial, practical, or emotional) to support others to whom people recognize relevant similarities, such as a shared interest in research or a shared health risk or experience with illness.
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In other words, although altruism describes a person's disposition toward others, solidarity is a practice that draws on and reinforces connections between people.
Prosocial motivations have been shown to underlie participation in biomedical research, 12 although scholarship on this topic has been criticized as overemphasizing altruistic behavior. 13 Against this backdrop, the notion of solidarity seems to better accommodate the simultaneity of self-interest and concern for others that has been found to motivate research participation in many studies. 14 In particular, in the context of data-rich medicine, solidarity has been described as an important motive that could be harnessed to enjoin people to participate in such research as well as a powerful way to frame such research endeavors. 15 Also in our study, both self-interest and prosocial motivations were at play. In our case, however, direct benefits or clinical relevance of the research seem to have played a minor role; although self-knowledge was a motivation for some participants, only a minority would have refrained from taking part if the tests had had no personal health relevance. We can only speculate about the reasons for this. It could be that the strong citizen-science rhetoric in the advertisement of the BGP, which calls on potential participants to "help science" at the same time that they "explore their inner self " (http://britishgut.org), is particularly attractive to people looking for an opportunity to support science as an added benefit to getting personalized results. More than one-third of our respondents said that they would not participate in a similar project within a commercial setting or where data would not be released for public benefit, which indicates that public benefit was indeed considered an important factor. A recent study on public attitudes toward commercial data use in the United Kingdom yielded similar findings. 16 It is therefore possible that for projects like the BGP to thrive, an emphasis on public benefits can help with recruitment.
Another finding of our study that is relevant to the design of similar studies is that most respondents considered risks Figure S2 online). This is an important indication that volunteers in projects such as the BGP or consumers of DTC genomics, who have been shown to be highly educated individuals, 17 do not expect to be harmed by their participation in CS projects of this kind. Apparently, participants themselves are-at least in our study-far less concerned about the risks of such projects than some outside commentators. 18 Overall, because direct benefits (clinical relevance) did not play any decisive role in motivating participation, the type of project we studied appears to have a very positive risk-to-benefit ratio in the eyes of participants. Only 13 of 151 respondents mentioned risk concerns. Only 7 respondents described specific risks, including data leakage, failure of anonymization, and bioterrorism, that they did not deem significant enough to deter them from participating in the BGP.
We found that age and education level seemed to be important factors in recruitment, with poorer recruitment among the young and less educated (7/10 (n = 99) respondents to our survey hold at least a college-or comparable-degree, whereas the overall figure for the United Kingdom is closer to 3/10). Given that bioresources reliant on self-recruitment of participants are already biased toward the resource-rich, 19 this bias may be exacerbated, especially in light of the accompanying crowdfunding campaigns and the financial costs that participants shoulder in these studies.
Four drivers of the well-known decline in research participation have been identified in the literature: an increase in the numbers of studies conducted, public mistrust of science, the burden of the studies for participants, and a general decrease in volunteerism. 20 Citizen-science approaches can help address the last three factors. Participatory designs can improve scientific literacy and give people more control over the aims of the study, thereby helping to address lack of trust. The burdensome nature of some studies might be countered by the desire for participation. Finally, in addition to utilizing new forms of digital interaction, our data indicate that decreasing volunteerism could be addressed by emphasizing prosocial reasons for participation in the recruitment strategies of citizen-science projects such as the BGP.
The desire of people for active participation in research can and should be mobilized and expanded. To ensure that marginalized groups in society are represented in studies that are likely to lead to health-related inferences at the population level, this should be accompanied by recruitment efforts tailored specifically to underserved groups, although different incentives may be required. In the case of crowdfunding, several participation formats should be offered, preferably encompassing "entrylevel" packages at the lowest possible cost. Overall, engaging participants more directly in funding, designing, and evaluating projects as well as in collecting samples and data could help ensure the continuation and expansion of data collection in the life sciences.
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